Of @ incident HIV-@ infections , @ occurred in individuals assigned tenofovir disoproxil fumarate ( incidence @ cases per @ person-years ) and @ were in those assigned emtricitabine plus tenofovir disoproxil fumarate ( @ cases per @ person-years ) ; HIV-@ incidence in the placebo group until discontinuation was two cases per @ person-years .